Literature DB >> 26777060

Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines.

Bhartesh A Shah1, Muhammad M Qureshi1, Scharukh Jalisi2, Gregory Grillone2, Andrew Salama3, Timothy Cooley4, Ken Zaner4, Osamu Sakai5, Minh Tam Truong6.   

Abstract

PURPOSE: To evaluate incorporation of National Cancer Comprehensive Network (NCCN) guidelines in decision making at a head and neck cancer (HNC) multidisciplinary tumor board (MDT) at an urban academic medical center. METHODS AND MATERIALS: A retrospective study of 176 HNC patients was performed. The extent to which MDT decisions and subsequent patient care incorporate NCCN guidelines was evaluated.
RESULTS: A total of 173 (98.3%) HNC patients received MDT recommendations according to NCCN guidelines. Of the 159 patients treated, 153 (96.2%) received treatment according to NCCN guidelines. The MDT recommended the highest available evidence-based NCCN category guideline in 78.0%. Subsequent treatment using the same or higher category MDT recommendation occurred in 87.0% of patients.
CONCLUSIONS: Evaluation of patients at an MDT using NCCN guidelines incorporates the highest level of evidence in approximately 80% of patients and translates well into subsequent care. Incorporation of the highest available NCCN guideline may be improved, although management should be individualized.
Copyright © 2016 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26777060     DOI: 10.1016/j.prro.2015.11.006

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  9 in total

1.  Lenalidomide, Bortezomib, and Dexamethasone (RVD) Regimen for Multiple Myeloma.

Authors:  Alexandra P Punke; J Aubrey Waddell; Dominic A Solimando
Journal:  Hosp Pharm       Date:  2017-01

Review 2.  The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.

Authors:  Paolo Bossi; Salvatore Alfieri
Journal:  Curr Treat Options Oncol       Date:  2016-10

3.  A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.

Authors:  Dong-Fang Meng; Rui Sun; Li-Xia Peng; You-Sheng Huang; Qin Yang; Dong-Hua Luo; Wei-Han Hu; Fang-Yun Xie; Wei Luo; Chong Zhao; Ling Guo; Hai-Qiang Mai; Ming-Yuan Chen; Ping Xie; Li-Sheng Zheng; Jun-Ping Yang; Yan Mei; Yuan-Yuan Qiang; Liang Xu; Chang-Zhi Li; Bi-Jun Huang; Chao-Nan Qian; Rui Sun
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

4.  A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis.

Authors:  Tongxin Liu; Quanquan Sun; Jing Chen; Fangzheng Wang; Bin Li; Weifeng Qin; Zhimin Ye; Fujun Hu
Journal:  Cancer Manag Res       Date:  2018-11-23       Impact factor: 3.989

Review 5.  Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management.

Authors:  Rossana Berardi; Francesca Morgese; Silvia Rinaldi; Mariangela Torniai; Giulia Mentrasti; Laura Scortichini; Riccardo Giampieri
Journal:  Cancer Manag Res       Date:  2020-09-30       Impact factor: 3.989

6.  Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines.

Authors:  Miguel Angel Noy; Benjamin J Rich; Ricardo Llorente; Deukwoo Kwon; Matthew Abramowitz; Brandon Mahal; Eric A Mellon; Nicholas G Zaorsky; Alan Dal Pra
Journal:  Adv Radiat Oncol       Date:  2021-10-29

7.  Improving adherence to lung cancer guidelines: a quality improvement project that uses chart review, audit and feedback approach.

Authors:  Abdulrahman Jazieh; Mohammad Omar Alkaiyat; Yosra Ali; Mohamed Ahmed Hashim; Nafisa Abdelhafiz; Ashwaq Al Olayan
Journal:  BMJ Open Qual       Date:  2019-08-26

Review 8.  Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.

Authors:  Ryan Bowman; Dana L Crosby; Arun Sharma
Journal:  Head Neck       Date:  2020-05-16       Impact factor: 3.147

9.  A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma.

Authors:  Mete Gundog; Hatice Basaran; Oktay Bozkurt; Celalettin Eroglu
Journal:  Braz J Otorhinolaryngol       Date:  2019-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.